ConvaTec Articles
Bristol-Myers sees 64% leap in 3rd quarter 2009 ongoing earnings
23 October 2009
Pharma/biotech mergers and acquisitions in 2008
12 January 2009
Bristol-Myers Squibb's 3rd-qtr 2008 profit triples due to big gain from $4.1B sales of ConvaTec
3 November 2008
Stock Commentary - New York week to May 5, 2008
12 May 2008
B-MS to sell its ConvaTec unit
12 May 2008
B-MS restructure cuts into 1st-qtr profit
5 May 2008
B-MS names Jean-Marc Huet as SVP and CFO
10 March 2008
Plavix rebound cuts B-MS' 4th-qtr 2007 loss and offsets $797M charge
11 February 2008
B-MS to cut 10% of workforce in a bid to save $1.5B in time for loss of Plavix patent
17 December 2007
Alltracel and ConvaTec sign wound care accord
19 November 2007
Smith & Nephew buys BASF's wound-care product, takes market lead
3 February 2000
B-MS Aligns Operations In China
2 October 1995
B-MS Opens Medical Device Unit In China
26 June 1995
B-MS Offers Staff Share Options In Spain
27 February 1995
WOUND HEALING: AN INDUSTRY IN TRANSITION
29 June 1992
Showing 1-16 of 16 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
